Ignite Creation Date:
2024-05-06 @ 6:50 PM
Last Modification Date:
2024-10-26 @ 2:55 PM
Study NCT ID:
NCT05800756
Status:
RECRUITING
Last Update Posted:
2023-04-06
First Post:
2023-03-23
Brief Title:
Pyrotinib Combined With TrastuzumabDalpiciclib and Letrozole for HRHER2 Breast Cancer
Sponsor:
Yantai Yuhuangding Hospital
Organization:
Yantai Yuhuangding Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-04
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-07-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-23
First Submit QC Date:
March 23 2023
Study First Post Date:
2023-04-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-23
Last Update Post Date:
2023-04-06
Last Update Post Date Type:
ACTUAL